Pacific Biosciences
PACB
#7425
Rank
HK$3.17 B
Marketcap
HK$10.50
Share price
-2.91%
Change (1 day)
9.00%
Change (1 year)

EPS for Pacific Biosciences (PACB)

EPS in 2025 (TTM): -HK$13.24

According to Pacific Biosciences 's latest financial reports the company's current EPS (TTM) is -HK$13.32. In 2024 the company made an earnings per share (EPS) of -HK$8.94 an increase over its 2023 EPS that were of -HK$9.48.

EPS history for Pacific Biosciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$13.2448.13%
2024-HK$8.94-5.79%
2023-HK$9.48-13.57%
2022-HK$10.9757.3%
2021-HK$6.98-841.67%
2020HK$0.94-121.79%
2019-HK$4.32-28.49%
2018-HK$6.04-13.48%
2017-HK$6.98
2015-HK$3.37-54.21%
2014-HK$7.36-24.69%
2013-HK$9.77-26.65%
2012-HK$13.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$139.28-1,145.29%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$64.43-583.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$35.04-362.94%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$60.35-552.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-HK$27.67 107.65%๐Ÿ‡บ๐Ÿ‡ธ USA